Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: A comparison with the effects of alfacalcidol

Journal of Nutritional Science and Vitaminology

Volumn 52, Issue 6, 2006, Pages 393-401

  Iwamoto, Jun ^a   Seki, Azusa ^b   Takeda, Tsuyoshi ^a   Sato, Yoshihiro ^c   Yamada, Harumoto ^d   Yeh, James K ^e  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamri Co Ltd   (Japan)

^c Mitate Hospital   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Alfacalcidol; Osteopenia; Ovariectomy; Rat; Risedronate

Indexed keywords

ALFACALCIDOL; DEOXYPYRIDINOLINE; OSTEOCALCIN; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DRUG MECHANISM; FEMALE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETIDRONIC ACID; FEMALE; FEMUR; HYDROXYCHOLECALCIFEROLS; OVARIECTOMY; PHOSPHORUS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TIBIA;

RATTUS;

EID: 33847153034     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.52.393     Document Type: Article

References (26)

1. Fleisch H. 1998. Bisphosphonates: Mechanism of action. Endocr Rev 19: 80-100.
2. Rogers MJ, Frith JC, Luckman SP, Coxon FR, Benford HL, Monkkonen J, Auriola S, Chilton KM, Russell RGG. 1999. Molecular mechanism of action of bisphosphonate. Bone 24 (5 Suppl): 73S-79S.
3. Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY. 2000. Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 85: 1895-1900.
4. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. 1999. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 282: 1344-1352.
5. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. 2001. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344: 333-340.
6. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. 1996. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535-1541.
7. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA. 2004. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350: 1189-1199.
8. Fujita T. 1990. Studies on osteoporosis in Japan. Metabolism 39 (Suppl 1): 39-42.
9. Aloia JF. 1990. Role of calcitriol in the treatment of postmenopausal osteoporosis. Metabolism 39 (Suppl 1): 35-38.
10. 3 on calcium balance and bone turnover and its effect of vertebral fracture rate. Metabolism 39 (Suppl 1): 30-34.
11. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54: 370-376.
12. 3. J Bone Miner Res 17: 1498-1511.
13. 2. J Bone Miner Metab 22: 404-414.
14. Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E. 2000. Alfacalcidol inhibits bone resorption and stimulate formation in an ovariectomized rats model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 15: 770-779.
15. Mosekilde L, Thomsen JS, Mackey MS, Phipps RJ. 2002. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats. Bone 27: 639-645.
16. Erben RG. 1997. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307-313.
17. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASMBR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
18. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. 2006. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats. J Nutr Sci Vitaminol 52: 1-8.
19. Hagaman JR. 1991. Age-related changes in rat trabecular endosteal and cortical bone demonstrated with scanning electron microscopy. Cells Mater 1: 37-46.
20. Kiebzak GM, Smith R, Gundberg CC, Howe JC, Sacktor B. 1988. Bone status of senescent male rats: chemical, morphometric, and mechanical analysis. J Bone Miner Res 3: 37-45.
21. Sato M, Vahle J, Schmidt A, Westmore M, Smith S, Rowley E, Ma LY. 2002. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology 143: 3230-3242.
22. Kimmel DB. 1996. Animal models for in vivo experimentation in osteoporosis research. In: Osteoporosis (Marcus R, Feldman D, Kelsey J, eds), p 671-690. Academic Press, San Diego.
23. Chappard D, Petitjean M, Alexandre C, Vico L, Minaire P, Riffat G. 1991. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts. J Bone Miner Res 6: 673-680.
24. Miltak BH, Burdette-Miller P, Schoenfeld D, Neer RM. 1996. Sequential effects of chronic PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat. J Bone Miner Res 11: 430-439.
25. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T. 2002. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 71: 69-79.
26. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ. 2002. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res 17: 1139-1147.